Literature DB >> 21686934

Reversible pulmonary hypertension in Whipple disease: a case report with clinicopathological implications, and literature review.

Pamela L Lyle1, Robert D Weber, Javier Bogarin, Tobias Kircher.   

Abstract

Whipple disease is a rare multisystemic disorder of infectious aetiology caused by Tropheryma whipplei. Pulmonary hypertension is a rare association for which the underlying pathophysiological mechanism is unclear. Our patient was a 54-year-old man with a 1-year history of progressive polyarticular arthritis, and worsening respiratory and gastrointestinal symptoms. Pulmonary artery catheterisation demonstrated moderate-to-severe pulmonary hypertension. Duodenal biopsies, with electron microscopy, were diagnostic of Whipple disease. Involvement by Whipple disease was also evident in the stomach, bone marrow and pulmonary pleura. A 2-week course of intravenous ceftriaxone was initiated and this was followed by a 1-year course of trimethoprim/sulfamethoxazole (160/800), once daily. Nine months into antibiotic treatment, a repeat echocardiogram showed normalisation of the size and function of the cardiac chambers, including the right atrium and right ventricle. There was complete resolution of the severe tricuspid insufficiency and pulmonary hypertension. Whipple disease is not generally considered as a possible cause of pulmonary hypertension but such awareness is important given that it may be potentially reversible with antibiotic therapy.

Entities:  

Year:  2009        PMID: 21686934      PMCID: PMC3029207          DOI: 10.1136/bcr.06.2008.0095

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Nazzareno Galiè; Lewis J Rubin; David Langleben; Werner Seeger; Guido Domenighetti; Simon Gibbs; Didier Lebrec; Rudolf Speich; Maurice Beghetti; Stuart Rich; Alfred Fishman
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

2.  Severe pulmonary hypertension in a patient with Whipple's disease.

Authors:  D A Morrison; R G Gay; D Feldshon; R E Sampliner
Journal:  Am J Med       Date:  1985-08       Impact factor: 4.965

3.  The diagnosis of Whipple's disease.

Authors:  W O Dobbins
Journal:  N Engl J Med       Date:  1995-02-09       Impact factor: 91.245

Review 4.  Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Société Nationale Française de Médecine Interne.

Authors:  D V Durand; C Lecomte; P Cathébras; H Rousset; P Godeau
Journal:  Medicine (Baltimore)       Date:  1997-05       Impact factor: 1.889

5.  Severe pulmonary hypertension reversed by antibiotics in a patient with Whipple's disease.

Authors:  H Riemer; R Hainz; C Stain; G Dekan; M Feldner-Busztin; P Schenk; C Müller; K Sertl; O C Burghuber
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

6.  [Whipple disease associated with pulmonary arterial hypertension. Jarisch-Herxheimer reaction after antibiotic therapy].

Authors:  S Peschard; A Brinkane; S Bergheul; L Crickx; B Gaudin; M Morcelet; R Levy
Journal:  Presse Med       Date:  2001-10-27       Impact factor: 1.228

7.  Class I and class II HLA antigens in a homogeneous Argentinian population with Whipple's disease: lack of association with HLA-B 27.

Authors:  J C Bai; A H Mota; E Mauriño; S Niveloni; F Grossman; L A Boerr; L Fainboim
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

8.  Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease.

Authors:  T Marth; M Roux; A von Herbay; S C Meuer; G E Feurle
Journal:  Clin Immunol Immunopathol       Date:  1994-08

9.  HLA antigens in Whipple's disease.

Authors:  W O Dobbins
Journal:  Arthritis Rheum       Date:  1987-01

10.  Whipple's disease: a histological, immunocytochemical, and electron microscopic study of the small intestinal epithelium.

Authors:  N L Ectors; K J Geboes; R M De Vos; H P Heidbuchel; P J Rutgeerts; V J Desmet; G R Vantrappen
Journal:  J Pathol       Date:  1994-01       Impact factor: 7.996

View more
  2 in total

1.  Reversible Pulmonary Hypertension Associated with Whipple's Disease.

Authors:  A Villa; G Nucera; A Kostihova; A Mazzola; P Marino
Journal:  Case Rep Pulmonol       Date:  2012-10-02

2.  Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease.

Authors:  George Stojan; Michael T Melia; Sandeep J Khandhar; Peter Illei; Alan N Baer
Journal:  BMC Infect Dis       Date:  2013-12-09       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.